Ai® (Influenza A/B Typing Rapid Diagnostic Test)

PCL’s SG Cap™ technology and multiplexing capabilities make it possible to simultaneously detect both A and B-type influenza viruses. PCL has developed a POCT test with >90% sensitivity and specificity that produces a diagnostic result within 30 minutes. PCL will soon provide an expanded line of POCT products for other pathogens that cause respiratory infections.

◆ Characteristics

• Influenza virus A, B and 2009 pandemic A/H1N1 diagnosis at the same time
• Rapid and accurate diagnosis for treatment and prohibition
• Testing time < 30 minutes
• Sensitivity > 90% (RIDT sensitivity ±60%)
• Fluorescent scanner, High sensitivity & specificity, automation, convenience
• More inexpensive and fast than RT-PCR

Product description

Product name	Ai® (Influenza A/B Typing Rapid Diagnostic Test)
Manufacturer	PCL Inc.
Category	Multiplex antigen detection kit
Specificity	>99.5%
Sensitivity	Influenza A (>90.0%), Influenza B (>90.0%)
Specimen	Nasopharyngeal & Throat Secretion
Immobilized material	Influenza A/B antibodies
Target material	Influenza A/B antigens
Assay method	Immunofluorescence
Volume of specimen	50ul
Assay time	<30 min